UBS’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q1
Sell
-80,999
Closed -$733K 6845
2013
Q4
$733K Buy
80,999
+46,693
+136% +$423K ﹤0.01% 2821
2013
Q3
$216K Sell
34,306
-38,318
-53% -$241K ﹤0.01% 3473
2013
Q2
$495K Buy
+72,624
New +$495K ﹤0.01% 2882